[DataCap Application] THE BioTek - THE BioTek

[duktig666]

Large Dataset Notary Application

To apply for DataCap to onboard your dataset to Filecoin, please fill out the following.

Core Information

• Organization Name: THE BioTek
• Website / Social Media: https://www.thebiotek.com/
• Total amount of DataCap being requested (between 500 TiB and 5 PiB): 5PiB
• Weekly allocation of DataCap requested (usually between 1-100TiB): 400TiB
• On-chain address for first allocation: f1s3gbistjbzwz2h55zu26jvwcz44l7ctfifvm7oq

Please respond to the questions below by replacing the text saying "Please answer here". Include as much detail as you can in your answer.

Project details

Share a brief history of your project and organization.

THE BioTek was created to take responsibility for both manufacturing and sourcing to help researchers and others to obtain high-quality compounds and chemical building blocks. Our goal is to simplify the searching and purchasing process for you and remove needless logistic and paperwork hurdles. Customer satisfaction is our priority put your needs first and go above and beyond to provide customized support.

Our Products: Chemical Compounds & Bioactive Reagents & Catalysts and Ligands & Materials Science & Inhibitors/Agonists & Protein Crystallization & Antibody Production & Recombinant Protein Expression

Chemical Compounds:
Virtually every laboratory uses a range of chemical reagents. These include, for example, indicators, standards, hydroxides, acids, salts, alcohols and solvents and buffer solutions. Chemical reagents are most often used in various types of research work, chemical analysis, in the preparation and also the production of other substances. The characteristics of laboratory applications and their scale determine the quantities and types of reagents. These substances are used for such analyses as: ion determination, separation of cation or anion mixtures, detection of specific ions and many others.

Bioactive Reagents:
A biologically active substance is a compound that engages in and influences life phenomena in a small amount. Biologically active substances include vitamins and coenzymes, hormones, antibiotics, neurotransmitters, and cytokines, for example. They mainly act as regulators of biological functions and are also being studied as candidate compounds for pharmaceuticals. Many of the bioactive compounds have actions in the body that are essential to health. They are being studied in the prevention of cancer, heart disease, and other diseases. Examples include lycopene, resveratrol, lignan, tannins, and indoles.

Catalysts and Ligands:
Over 80% of all chemical products are produced by means of catalytic processes. Catalysis underpins both modern industrial and academic chemistry, improving reaction sustainability, shaping reaction selectivity and facilitating new reaction pathways. Ligand design occupies a central place in organic synthesis and catalysis. The ability of ligands to engender a variety of useful properties of organometallic complexes is the major enabling force for the discovery of new catalytic reactions, activation of small molecules, stabilization of reactive organometallic species and bonding states of elements.

Materials Science:
Materials Science is an interdisciplinary subject, spanning the physics and chemistry of matter, engineering applications and industrial manufacturing processes. Materials scientists study the relationships between the structure and properties of a material and how it is made. They also develop new materials and devise advanced processes for manufacturing them efficiently. Materials Science is vital for developments in nanotechnology, quantum computing, spintronics, energy storage and nuclear energy, as well as medical technologies such as bone replacement materials and drug delivery.

Inhibitors/Agonists:
Inhibitors are compounds that can bind to a protein, such as an enzyme and decrease its activity. Inhibitors play a crucial role in fundamental physiological and biochemical processes and are essential to many aspects of biomedical research especially as the pharmaceutical industry continues to shift more towards biologicals for new drug candidates. An agonist is a molecule capable of binding to and functionally activating a target. Conventional agonists increase the proportion of activated receptors while inverse agonists stabilize receptors in an inactive conformation and act similarly to competitive antagonists.

What is the primary source of funding for this project?

Company

What other projects/ecosystem stakeholders is this project associated with?

None

Use-case details

Describe the data being stored onto Filecoin

Scientific research data

Where was the data in this dataset sourced from?

Company

Can you share a sample of the data? A link to a file, an image, a table, etc., are good ways to do this.

https://bafybeidjlr6iiht7xngi2cw5xtawpcjjbaukwgk2mklpwfapgr4eny4sbe.ipfs.dweb.link/

Confirm that this is a public dataset that can be retrieved by anyone on the Network (i.e., no specific permissions or access rights are required to view the data).

Yes

What is the expected retrieval frequency for this data?

1-2 times a year

For how long do you plan to keep this dataset stored on Filecoin?

540 Days

DataCap allocation plan

In which geographies (countries, regions) do you plan on making storage deals?

Hong Kong & Singapore

How will you be distributing your data to storage providers? Is there an offline data transfer process?

We will determine the method of data transfer based on the geographic location of the SPs.We support Online data transfer & offline data transfer.

How do you plan on choosing the storage providers with whom you will be making deals? This should include a plan to ensure the data is retrievable in the future both by you and others.

To ensure secure storage of data, we store data to multiple SPs. We will select SPs based on geographic location, and we require SPs to provide retrieval

How will you be distributing deals across storage providers?

Evenly distributed to multiple SPs

Do you have the resources/funding to start making deals as soon as you receive DataCap? What support from the community would help you onboard onto Filecoin?

Yes

[large-datacap-requests[bot]]

Thanks for your request!

Heads up, you’re requesting more than the typical weekly onboarding rate of DataCap!

[large-datacap-requests[bot]]

Thanks for your request! Everything looks good. :ok_hand:

A Governance Team member will review the information provided and contact you back pretty soon.

[Sunnyiscoming]

Can you provide more data samples related with the data you will store to prove that you have 5 PB data? Videos would be better. Can you explain your data composition and provide sufficient data samples separately? How many copies will you store? What's the relationship between you and the organization? Can you provide more detailed information about other storage providers participated in this program, such as you can list SPs you have contacted with at present?

[Sunnyiscoming]

Any update here?

[duktig666]

@Sunnyiscoming Hello Sunny, Our data composition comprises of data generated in the course of scientific research. We plan to store data to multiple storage providers to ensure data security. We are applying for a DataCap on behalf of an organization to store data into filecoin. We have only communicated with f01909429 and f01412203 so far. I sent a verification email, please check:

[kevzak]

Hello FYI - @duktig666 informed me this is for E-Fil Pilot @raghavrmadya @Sunnyiscoming

[kevzak]

@duktig666 since this is a private dataset, please complete the exceptions proposal also to provide more details about the data storage plan. Thanks

[flyworker]

can you tell me why as a US based company want to store data in Hong Kong & Singapore, isn't it make more sense to store in NA or EU? Thanks

[duktig666]

can you tell me why as a US based company want to store data in Hong Kong & Singapore, isn't it make more sense to store in NA or EU? Thanks

@flyworker The company has two parts, the United States and China have teams, the Chinese team is in Shenzhen and Hong Kong, the main body of research and development is in China, and the data processing is in Hong Kong. thank you

[kevzak]

@duktig666 if this application is meant for E-Fil+, I'm awaiting the registration form submission from the client: https://docs.google.com/forms/d/e/1FAIpQLSeAaM0duQFDGUmQ5c7e--FVez7fXGOkLZlUPSkfpbBMfmwXsw/viewform

[flyworker]

if the company has two parts, which it the major application entity?

[Sunnyiscoming]

Any update here?

[large-datacap-requests[bot]]

Thanks for your request! :exclamation: We have found some problems in the information provided. We could not find Organization Name field in the information provided We could not find Website \/ Social Media field in the information provided We could not find Total amount of DataCap being requested (between 500 TiB and 5 PiB) field in the information provided We could not find Weekly allocation of DataCap requested (usually between 1-100TiB) field in the information provided We could not find On-chain address for first allocation field in the information provided We could not find Data Type of Application field in the information provided

Please, take a look at the request and edit the body of the issue providing all the required information.

[github-actions[bot]]

This application has not seen any responses in the last 10 days. This issue will be marked with Stale label and will be closed in 4 days. Comment if you want to keep this application open.

[github-actions[bot]]

This application has not seen any responses in the last 14 days, so for now it is being closed. Please feel free to contact the Fil+ Gov team to re-open the application if it is still being processed. Thank you!